Testosterone cypionate 250 mg/mL injection packaged in an amber glass… — Class II drug recall D-0138-2015
Terminated recall by Martin Avenue Pharmacy, Inc., reported 2014-11-05, distributed nationwide. Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounde
| Recall number | D-0138-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Martin Avenue Pharmacy, Inc., Naperville, IL, United States |
| Recall initiated | 2014-08-27 |
| Classified | 2014-10-29 |
| Reported by FDA | 2014-11-05 |
| Terminated | 2018-05-31 |
| Distributed | Nationwide (US) |
| Quantity | 20 ml |
| Reason classes | sterility |
| Expiration dates | 2014-10-30 |
Product
Testosterone cypionate 250 mg/mL injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
Reason for recall
Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0138-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.